Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

301
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
301
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

197
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
197
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

275
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
275
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.2K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.2K
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

279
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
279

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biodiversity buffers forest ecosystems from compound climate extremes.

Nature communications·2026
Same author

Prognostic incremental value of perivascular adipose tissue in myocardial infarction with non-obstructive coronary arteries: a multicenter cohort study.

Quantitative imaging in medicine and surgery·2026
Same author

Scaling biodiversity-stability relationships from populations to meta-communities across trophic levels.

Nature communications·2026
Same author

Divergence From Temperate Models: Pollution Dominance and Stochastic Assembly in a Continental Freshwater System Under Compressed Modernity.

Global change biology·2026
Same author

Global synthesis reveals systematic variation in trophic transfer efficiency across and within ecosystems.

Science advances·2026
Same author

Statistical shape refinement and genetic algorithm calibration of design response spectra based on strong-motion records.

PloS one·2026

Related Experiment Video

Updated: Feb 16, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Deciphering the Relationship between Obesity and Various Diseases from a Network Perspective.

Lei Chen1,2, Yu-Hang Zhang3, JiaRui Li4

  • 1School of Life Sciences, Shanghai University, Shanghai 200444, China. chen_lei1@163.com.

Genes
|December 21, 2017
PubMed
Summary

Obesity is linked to nutrition, endocrine, psychiatric, and bone diseases. Analyzing protein-protein interactions reveals molecular mechanisms underlying these co-occurring conditions, aiding prevention strategies.

Keywords:
OMIM disease classdisease geneobesityprotein–protein interaction

More Related Videos

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.0K
Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.8K

Related Experiment Videos

Last Updated: Feb 16, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.0K
Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.8K

Area of Science:

  • Genetics and Bioinformatics
  • Molecular Biology
  • Public Health

Background:

  • Rising global obesity rates present significant health challenges.
  • The molecular pathogenesis of obesity requires further elucidation beyond energy imbalance.
  • Obesity may share underlying genetic factors with other diseases.

Purpose of the Study:

  • To investigate the molecular associations between obesity and other diseases using a protein-protein interaction (PPI) network.
  • To identify disease categories closely related to obesity based on gene interactions.

Main Methods:

  • Mapping obesity genes and disease-associated genes onto a PPI network.
  • Calculating interaction scores between gene sets based on PPI data.
  • Analyzing network topology to infer disease relationships.

Main Results:

  • Nutrition and endocrine-related diseases show the strongest association with obesity.
  • Psychiatric and bone-related diseases are also significantly linked to obesity.
  • Identified numerous novel obesity-disease associations.

Conclusions:

  • The study highlights interconnected molecular mechanisms between obesity and various disease categories.
  • Findings support the role of genetic factors in obesity pathogenesis and co-morbidity.
  • Provides insights for potential therapeutic targets and preventative measures for obesity and related conditions.